On the morning of March 18, the 30th anniversary conference of Rongchang was held in Yantai Bajiaowan International Convention and Exhibition Center.

Jointly established the "Yantai Yeda International Incubator for Biomedical Innovation" with the Development Area Management Committee.

On March 18, Rongchang moved to the Biopharmaceutical Park in Yantai Economic and Technological Development Zone.

Tongji University set up “Tongji University Yantai Academy” in Rongchang Biopharmaceutical Park.

On January 9, Rongchang, Tongji University and the Management Commission of Yantai Development Zone jointly signed an agreement in Beijing to build the Joint Platform and Development Base for New Biologic Drugs.

Rongchang dedicated to the original formulation of innovative biological drugs of proprietary intellectual property rights.

Rongchang gained the GMP certificate issued by CFDA.

Rongchang established MedGen, Ltd. jointly with a famous Chinese scholar team in America and began to develop the new gene-based antitumor drug Vascular Endothelial Growth Inhibitor (Endu). The new project was included in the Key Projects of Shandong Provincial Torch Program in 1999 and 2000, and it was recognized as the key project in the pharmaceutical industry in the 1999 Technology Development Plan of Shandong Province.

Rongchang was awarded as Excellent Technological Private Enterprise of Shandong Province by Science and Technology Committee of Shandong Province.

New hemorrhoids drug “Rongchang Gangtai” anti-hemorrhoids patch officially enter into production and launched in market. The new drug was developed under the guidance of traditional Chinese medical theories and produced with modern technologies.